Search results - 6 results
Characterisation of tetanus monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
antigen. In this paper we report the results of the comprehensive characterisation of a panel of mAbs against tetanus with a view to select antibodies that can be used for development of an in vitro potency ...
Characterisation of diphtheria monoclonal antibodies as a first step towards the development of an in vitro vaccine potency immunoassay.
having been specifically developed as alternatives to in vivo potency tests. These methods require at least one well characterised monoclonal antibody (mAb) that is specific for the target antigen. In this ...
Regulatory Position on Specification Settings
Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: PDA Europe Conference Vaccines. Featuring WHO on Challenges in Vaccines Supply to Developing Countries, ...
Round table discussion on posters: comparability and testing challenges
Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: PDA Europe Conference Vaccines. Featuring WHO on Challenges in Vaccines Supply to Developing ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
Future Development, Meeting Management, Issue Herriot,J., Vanden Bossche,G., Lausanne, Switserland (2013) Keywords: a Activity additional ALL Aluminium an Antioxidant Antioxidants application AS assessment ...
Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.
lungs from B6 mice, subsequently challenged. Therefore, this technique may be useful for the definition of protective antigens of M. tuberculosis and the development of a more effective ...